TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/12/18 17:38 | 1/10/18 | PURE | Pure Bioscience, Inc. | DE | Chem | Chem | Miscellaneous Chemical Produc | Lambert Henry R. | CA | DO | CEO | S.m | -39 | 0.9289 | 0 | -42 | -8 | 498 | D | ||||||||||||||
4/13/17 19:39 | 4/11/17 | PURE | Pure Bioscience, Inc. | DE | Chem | Chem | Miscellaneous Chemical Produc | Lambert Henry R. | CA | DO | CEO | S.m | -3 | 0.9500 | 0 | -3 | -1 | 340 | D | ||||||||||||||
7/31/15 16:49 | 11/1/13 | PURE | Pure Bioscience, Inc. | DE | Chem | Chem | Miscellaneous Chemical Produc | Lambert Henry R. | CA | DO | CEO | P.a | 30 | 0.7000 | 0 | 43 | 9 | 543 | D | ||||||||||||||
11/5/13 18:26 | 11/1/13 | PURE | Pure Bioscience, Inc. | DE | Chem | Chem | Miscellaneous Chemical Produc | Lambert Henry R. | CA | DO | CEO | P | 30 | 0.7500 | 0 | 40 | 8 | 540 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |